SCHEMBL19989503

SCHEMBL19989503

Cc1cc(S(=O)(=O)NC2CCOCC2)ccc1Br

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.57
SMN1; SMN2 Q16637 2/20 0.50
POLB P06746 1/20 0.50
GAA P10253 1/20 0.50
PIK3CD O00329 2/20 0.46
PIK3CB P42338 2/20 0.46
MTOR P42345 2/20 0.46
PIK3CG P48736 2/20 0.46
HTT P42858 2/20 0.46
TDP1 Q9NUW8 2/20 0.46
KMT2A Q03164 1/20 0.46
CYP3A4 P08684 1/20 0.46
TSHR P16473 1/20 0.46
MAPK1 P28482 1/20 0.46
KDM4E B2RXH2 1/20 0.45
RECQL P46063 1/20 0.45
MMP1 P03956 1/20 0.44
MMP2 P08253 1/20 0.44
MMP3 P08254 1/20 0.44
MME P08473 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29859380 1.00 ALDH1A1 (0.57) ALDH1A1SMN1; SMN2POLBGAAPIK3CD
SCHEMBL2372122 0.90 ALDH1A1 (0.65) ALDH1A1SMN1; SMN2POLBGAAHTT
SCHEMBL19994841 0.86 ALDH1A1 (0.73) ALDH1A1SMN1; SMN2POLBGAAHTT
SCHEMBL848293 0.83 ALDH1A1 (0.57) ALDH1A1SMN1; SMN2POLBGAAPIK3CD
SCHEMBL1727236 0.83 ALDH1A1 (0.57) ALDH1A1SMN1; SMN2POLBGAAPIK3CD
SCHEMBL29498481 0.83 ALDH1A1 (0.57) ALDH1A1SMN1; SMN2POLBGAAPIK3CD
SCHEMBL15646817 0.82 POLB (0.46) ALDH1A1SMN1; SMN2POLBPIK3CGHTT
SCHEMBL29859535 0.81 ALDH1A1 (0.55) ALDH1A1SMN1; SMN2POLBGAAPIK3CG
SCHEMBL19989019 0.81 ALDH1A1 (0.55) ALDH1A1SMN1; SMN2POLBGAAPIK3CG
SCHEMBL23052553 0.80 ALDH1A1 (0.53) ALDH1A1SMN1; SMN2POLBGAAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109715608-B Indazole compounds for use in tendon and/or ligament injuries 诺华股份有限公司 2022-08-05 CN disclosed
EP-3515894-B1 INDAZOLE COMPOUNDS FOR USE IN TENDON AND/OR LIGAMENT INJURIES NOVARTIS AG (CH) 2021-04-07 EP disclosed
EP-3515894-A1 INDAZOLE COMPOUNDS FOR USE IN TENDON AND/OR LIGAMENT INJURIES Novartis AG (CH) 2019-07-31 EP disclosed
US-10112907-B2 Substituted indazoles for treating tendon and/or ligament injuries NOVARTIS AG (CH) 2018-10-30 US disclosed
US-20180086716-A1 Indazole Compounds for Use in Tendon and/or Ligament Injuries NOVARTIS INSTITUTE FOR FUNCTIONAL GENOMICS, INC., DBA THE GENOMICS INSTITUTE OF THE NOVARTIS RESEARCH FOUNDATION 2018-03-29 US disclosed
WO-2018055550-A1 INDAZOLE COMPOUNDS FOR USE IN TENDON AND/OR LIGAMENT INJURIES NOVARTIS AG (CH) 2018-03-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10112907-B2 Substituted indazoles for treating tendon and/or ligament injuries SLC10A2, MMP1, TNNI3 ALDH1A1 442/4885SMN1; SMN2 2255/4885POLB 3965/4885
US-20180086716-A1 Indazole Compounds for Use in Tendon and/or Ligament Injuries MMP1, SLC10A2, TNNI3 ALDH1A1 414/4885SMN1; SMN2 2704/4885POLB 3540/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.